Skip to main content
. 2018 Feb 2;9(10):2698–2704. doi: 10.1039/c7sc05484j

Table 2. Device parameters of (FAPbI3)0.85(MAPbBr3)0.15-based dopant-free PVSCs using BTF1–4, spiro-OMeTAD and PEDOT:PSS as HTMs.

HTMs Device V oc (V) J sc (mA cm–2) FF (%) PCE (%)
BTF1 n–i–p 0.91(0.90 ± 0.01) 17.5(16.2 ± 1.3) 62.6(60.7 ± 1.8) 9.97(8.84 ± 1.12)
BTF2 n–i–p 0.85(0.84 ± 0.02) 19.5(18.0 ± 1.4) 63.1(60.7 ± 2.1) 10.45(9.16 ± 1.02)
BTF3 n–i–p 1.08(1.07 ± 0.02) 20.4(19.2 ± 1.1) 74.3(72.4 ± 1.8) 16.34(15.28 ± 1.13)
BTF4 n–i–p 1.06(1.05 ± 0.01) 22.5(21.5 ± 1.1) 75.6(73.7 ± 1.9) 18.03(16.97 ± 1.05)
Spiro-OMeTAD n–i–p 1.02(1.01 ± 0.01) 14.3(13.0 ± 1.3) 64.0(62.4 ± 1.5) 9.33(8.21 ± 1.09)
BTF1 p–i–n 0.96(0.95 ± 0.01) 16.1(14.9 ± 1.2) 72.4(70.7 ± 1.5) 11.19(10.02 ± 0.98)
BTF2 p–i–n 0.91(0.90 ± 0.02) 17.7(16.5 ± 1.1) 74.3(72.7 ± 1.6) 11.96(10.51 ± 1.02)
BTF3 p–i–n 1.03(1.02 ± 0.01) 19.3(18.3 ± 1.1) 75.9(74.1 ± 1.7) 15.09(14.14 ± 0.96)
BTF4 p–i–n 1.03(1.01 ± 0.02) 21.5(20.5 ± 1.0) 76.8(75.3 ± 1.5) 17.01(16.14 ± 0.85)
PEDOT:PSS p–i–n 0.96(0.94 ± 0.01) 22.4(21.5 ± 1.0) 76.4(74.7 ± 1.6) 16.42(15.48 ± 0.94)